News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Trials Contractor Cvitkovic To Take Equity In Peplin Biotech



10/19/2005 5:12:24 PM

French-based clinical trial contractor Cvitkovic and Associates Consultants (CAC) will take equity in Brisbane cancer-drug developer Peplin Biotech (ASX:PEP) and establish a 'dedicated operation' in Australia.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES